Page 100 - Genomic Medicine in Emerging Economies
P. 100

Familial Adenomatous Polyposis    89




           these studies (29%–88%), which may be explained by variable selection cri-
           teria of patients and technical approaches used for mutation detection. For
           example, Cuba reported the lowest percentage of mutations (29%) since their
           study was done by heteroduplex technique. On the contrary, when a combi-
           nation of SSCP, PTT and Sanger sequencing was used in classic FAP patients
           the percentage of mutation carriers rose to 88% (Table 5.5). On average, con-
           sidering all studies, 67% of patients have a mutation in APC, but the higher
           mutation rate is obtained in patients showing a classic FAP phenotype (79%),
           compared to patients with attenuated FAP (40%). Mutations were localized
           mainly in exon 15 of APC (82%), specifically between cDNA nucleotides 2486
           and 5365 (codon 829 and 1789). This part of the gene includes the “muta-
           tional cluster region” described for APC, which includes codon 1309, already
           identified as mutated in 19% of Latin American patients. New mutations have
           been reported in three publications representing between 36% and 53% of all
           mutations detected. The significant rate of novel mutations reported between
           studies may be attributed to the scarce information in databases regarding
           Latin American patients.
           In summary, 76 different mutations have presently been reported until today
           for the Latin American population, the majority being point mutations (De
           Jesus-Monge  et  al.,  2010),  three gene  rearrangements involving  the deletion
           of the APC gene or its partial duplication. For this reason DNA sequencing is
           highly effective in the screening of mutations in the FAP patients since only
           few patients will need to be studied for gene rearrangements. Finally, seven
           mutations are shared between different Latin American countries, two of which
           are localized in the hot spots already defined, and present in patients from all
           Latin American countries. Among shared mutations we found the following:
           c.2626C>T, c.4348 C>T and c.4393_4394delAG present in Brazil and Argen-
           tina; c.3783_3784delTT and c.4280delC present in Argentina and Chile; the hot
           spot c.3183_3187delACAAA (codon 1061) identified in Argentina, Brazil, Cuba,
           Mexico and Puerto Rico; and the hot spot c.3927_3931delAAAGA (codon 1309)
           present in Argentina, Brazil, Chile, Cuba, Mexico and Puerto Rico.

           MUTYH Associated Polyposis
           In 2002,  Al-Tassan et  al. (2002) determined that some FAP patients with
           no mutation in the APC gene have germinal mutation in the MUTYH gene.
           This type of polyposis, called MUTYH Associated Polyposis (MAP), was char-
           acterized as an autosomic recessive disease with an indistinguishable phe-
           notype from FAP, which is caused by mutations in the APC gene (Al-Tassan
           et al., 2002; Sampson et al., 2003). The MUTYH gene codes for a DNA gly-
           cosylase enzyme that repairs oxidative DNA damages caused by ROS (Oht-
           subo, 2000; Cheadle and Sampson, 2003). The more stable oxidized guanine
   95   96   97   98   99   100   101   102   103   104   105